Skip to main content
رجوع
LQDA logo

Liquidia Corporation

جودة البيانات: 100%
LQDA
NASDAQ Healthcare Biotechnology
KWD 35.20
▼ KWD 0.30 (-0.85%)
القيمة السوقية: 3.10B
نطاق اليوم
KWD 34.21 KWD 36.00
نطاق 52 أسبوعًا
KWD 11.26 KWD 46.67
حجم التداول
632,511
متوسط 50 يوم / 200 يوم
KWD 37.72 / KWD 27.42
الإغلاق السابق
KWD 35.50

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -45.0 0.3
P/B 69.3 2.9
ROE % -113.0 3.7
Net Margin % -43.5 3.8
Rev Growth 5Y % 87.3 10.0
D/E 4.4 0.2

السعر المستهدف للمحللين

Hold
KWD 50.670 +43.9%
Low: KWD 47.000 High: KWD 55.000
مكرر الربحية المستقبلي
14.7
ربحية السهم المستقبلية
KWD 2.411
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
590 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 6.118
KWD 3.596 – KWD 8.338
1.4 B 2
FY2029 KWD 5.658
KWD 3.326 – KWD 7.711
1.2 B 4
FY2028 KWD 5.091
KWD 0.440 – KWD 8.939
1.1 B 6

النقاط الرئيسية

Revenue grew 87.34% annually over 5 years — strong growth
Debt/Equity of 4.42 — high leverage
Negative free cash flow of -40.02M
PEG of 0.83 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 943.84%
Capital efficient — spends only 2.74% of revenue on capex

النمو

Revenue Growth (5Y)
87.34%
Revenue (1Y)1031.18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-112.97%
ROIC-15.88%
Net Margin-43.53%
Op. Margin-32.45%

الأمان

Debt / Equity
4.42
Current Ratio1.40
Interest Coverage-2.13

التقييم

P/E Ratio
-45.00
P/B Ratio69.31
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 1031.18% Revenue Growth (3Y) 200.88%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 87.34% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 158.32M Net Income (TTM) -68.92M
ROE -112.97% ROA -21.02%
Gross Margin 97.21% Operating Margin -32.45%
Net Margin -43.53% Free Cash Flow (TTM) -40.02M
ROIC -15.88% FCF Growth (3Y) N/A
Safety
Debt / Equity 4.42 Current Ratio 1.40
Interest Coverage -2.13 Dividend Yield 0.00%
Valuation
P/E Ratio -45.00 P/B Ratio 69.31
P/S Ratio 19.59 PEG Ratio 0.83
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 3.10B Enterprise Value 3.11B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 158.32M 14.00M 17.49M 15.94M 12.85M
Net Income -68.92M -130.39M -78.50M -41.02M -34.58M
EPS (Diluted) -0.80 -1.66 -1.21 -0.67 -0.70
Gross Profit 153.90M 8.12M 14.60M 13.08M 9.83M
Operating Income -51.38M -121.29M -73.38M -38.77M -33.80M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 327.93M 230.31M 118.33M 129.20M 93.73M
Total Liabilities 283.19M 153.04M 71.04M 38.78M 28.46M
Shareholders' Equity 44.75M 77.28M 47.29M 90.42M 65.27M
Total Debt 197.93M 122.39M 49.54M 24.46M 16.08M
Cash & Equivalents 190.68M 176.48M 83.68M 93.28M 57.49M
Current Assets 190.68M 185.11M 89.90M 99.81M 61.28M
Current Liabilities 135.77M 41.78M 18.55M 8.80M 7.33M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Full Throttle
#6 of 146
77

النشاط الأخير

دخل Full Throttle
Mar 24, 2026